Study S000900

Liraglutide Improve Cognitive Function in Patients With Type 2 Diabetes Mellitus

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT05360147
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE3
Masking: SINGLE
Status: COMPLETED
Enrollment: 30
Start: 2021-01-20
Primary completion: 2021-04-20
Lead sponsor: Third Military Medical University
Conditions: Type 2 Diabetes Mellitus
Interventions: DRUG:Liraglutide; DRUG:Oral antidiabetic drugs: Metformin, Sulfonylureas (2nd generation), Thiazolidinediones, α-Glucosidase inhibitors, and Glinides
Results posted: FALSE

Registered primary outcomes

Changes in cognitive function from baseline to 12 weeks [0 week, 12 week]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.